Heymach, J. V., Liu, G., Xing, L., Greillier, L., Thomas, J., Yazici, O., Sun, M., Fan, Y., Zhou, C., Wang, M., Memmott, R. M., Kowalski, D., Shu, C. A., Shum, E., Tostivint, E. P., Bertolini, F., Hinojal, G. F., Antonuzzo, L., Wang, Y., Zhou, C. (2026). Sunvozertinib monotherapy versus platinum-based chemotherapy as first-line treatment for advanced NSCLC with EGFR exon20ins: Primary analysis of a multinational phase 3 randomized study (WU-KONG28).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba8500